RemeGen Co., Ltd. (HKG:9995)
Hong Kong
· Delayed Price · Currency is HKD 41.35
+6.05 (17.14%)
Apr 24, 2025, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 26.90 billion as of April 24, 2025. Its market cap has increased by 7.05% in one year.
Market Cap
26.90B
Enterprise Value
28.93B
Revenue
1.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
41.35
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has decreased from 33.39B to 26.90B, a decrease of -19.44%. That is a compound annual growth rate of -4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 24.36B | 73.95% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 211.76B |
| Hansoh Pharmaceutical Group Company | 140.94B |
| JD Health International | 115.75B |
| WuXi Biologics | 91.89B |
| Innovent Biologics | 84.80B |
| Akeso | 83.38B |
| Alibaba Health Information Technology | 76.23B |
| CSPC Pharmaceutical Group | 70.59B |